Trial Profile
Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients (EMINENT Study)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Jul 2018
Price :
$35
*
At a glance
- Drugs Monascus (Primary) ; Atorvastatin
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms EMINENT
- 14 Oct 2014 New trial record